Advertisement

Topics

Video Interview: This Biotech Wants to Take Over the NOTCH Space

08:51 EDT 4 May 2017 | Labiotech.eu

Cellestia, based in Basel, is a biotech spin-off from EPFL, developing new compounds targeting the NOTCH pathway for the treatment of cancer. Its CEO, Michael Bauer, talked to Philip at our recent meetup in Basel and explained what sets Cellestia ...

This awesome article Video Interview: This Biotech Wants to Take Over the NOTCH Space appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: Video Interview: This Biotech Wants to Take Over the NOTCH Space

NEXT ARTICLE

More From BioPortfolio on "Video Interview: This Biotech Wants to Take Over the NOTCH Space"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...